skip to navigation skip to content


These ventures have just started at Accelerate Cambridge. They are at various stages of development, with some having already raised their first seed round.

Cambridge Biologicals Co

Cambridge Biologicals Co is established by Dr Chiwen Chang in 2018 to commercialise a project developed in the University. It is a first-in-class immunotherapy for inflammatory and angiogenesis related diseases like rheumatoid arthritis and cancers etc. It's in an early stage of fundraising for pre-clinical and clinical trials.


CapsuleBot is an orally administrated drug delivery capsule that combines wireless capsule endoscopy technology with drug release robotics to deliver therapeutic compounds right to the disease target. Colorectal cancer is the third most common cancer in the western world, treated mainly with systemically administrated chemotherapy. CapsuleBot allows for localised drug delivery right to the cancerous site, thereby reducing side effects and increasing efficiency of treatment. The team behind CapsuleBot is formed of four skilled scientists with a vision to develop the most effective drug delivery system for the treatment of colorectal cancer. CapsuleBot - smart capsule for better health!

Capsulebot logo


DrML provides an intelligent health management platform which empowers patients to manage their skin issues and supports healthcare professionals in their decision-making to improve patient care through intelligent, real-time data sharing and triaging.

Kalium Diagnostics

Kalium Diagnostics is developing the world's first blood potassium test suitable for home use. The test will help chronic kidney patients and suffers of rare diseases to manage their health away from hospitals and clinics, improving health and lifestyles and significantly reducing the costs of healthcare provision. Our team combines world-class clinical, scientific and product development expertise.

Kalium diagnostics logo


Seedlink are designing a low-cost, easy-to-use chemical swab which tests for pesticide residue on food crops. A large percentage of cocoa exported from West Africa is rejected because of high levels of pesticide residue. Current testing methods are lab-based and far out of reach for smallholder farmers or cooperatives. Seedlink allows testing to take place at the source, so farmers can measure and control their pesticide use. This also gives smallholder farmers the ability to know whether their cocoa passes EU regulations for pesticide use, enabling those farmers to access the lucrative export markets directly.